Therapeutic-products Madison

Quintessence Biosciences, Inc. is a biopharmaceutical company focused on development of novel protein-based therapeutics as anti-cancer agents. The Company's products are based on the EVadeÔ Ribonuclease Technology which allows for the engineering of ...

Quintessence Biosciences, Inc. is a biopharmaceutical company focused on development of novel protein-based therapeutics as anti-cancer agents. The Company's products are based on the EVadeÔ Ribonuclease Technology which allows for the engineering of ...

SLIL is a world leader in the field of polyamine analog research and is developing new therapies for cancer and other diseases. SLIL also has an exclusive license to the Sequential Pathogenesis technology and has the opportunity to develop therapeutic ...

Quintessence Biosciences, Inc. is a biopharmaceutical company focused on development of novel protein-based therapeutics as anti-cancer agents. The Company's products are based on the EVadeÔ Ribonuclease Technology which allows for the engineering of ...

Quincy Bioscience researches, develops and plans to market therapeutic compounds for the treatment of neurodegenerative disorders, such as Alzheimer's disease, Parkinson's disease, stroke, Huntington's disease, and Amyotrophic Lateral Sclerosis (ALS) ...

Quincy Bioscience researches, develops and plans to market therapeutic compounds for the treatment of neurodegenerative disorders, such as Alzheimer's disease, Parkinson's disease, stroke, Huntington's disease, and Amyotrophic Lateral Sclerosis (ALS) ...

Quincy Bioscience researches, develops and plans to market therapeutic compounds for the treatment of neurodegenerative disorders, such as Alzheimer's disease, Parkinson's disease, stroke, Huntington's disease, and Amyotrophic Lateral Sclerosis (ALS) ...